Impaired lipid levels and inflammatory response in rats exposed to cadmium

EXCLI Journal

Volumn 11, Issue , 2012, Pages 677-687

  Afolabi, Olusegun Kayode ^a   Oyewo, Emmanuel Bukoye ^a   Adekunle, Adeniran Sanmi ^a   Adedosu, Olaniyi Temitope ^a   Adedeji, Adebayo Lawrence ^a  

^a LADOKE AKINTOLA UNIVERSITY OF TECHNOLOGY   (Nigeria)

Author keywords

Cadmium; Cholesterol; Cytokines; Hypertriglyceridemia; OxLDL; Paraoxonase

Indexed keywords

ARYLDIALKYLPHOSPHATASE; CADMIUM; DRINKING WATER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 2; INTERLEUKIN 6; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; OXIDIZED LOW DENSITY LIPOPROTEIN; PHOSPHOLIPID; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ARTICLE; CADMIUM POISONING; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE RESPONSE; ENZYME ACTIVITY; HYPERTRIGLYCERIDEMIA; INFLAMMATION; LIPID BLOOD LEVEL; LIPID PEROXIDATION; MALE; NONHUMAN; PROTEIN CONTENT; PROTEIN EXPRESSION; RAT; TOXICITY TESTING;

EID: 84867610625     PISSN: None     EISSN: 16112156     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Aguilar-Salinas CA, Olaiz G, Valles V, Torres JMR, Pérez FJG, Rull JA et al. High prevalence of low HDL cholesterol concentrations and mixed hyperlipidemia in a Mexican nationwide survey. J Lipid Res 2001;42:1298-307.
2. Ahotupa M, Vasankari TJ. Baseline diene conjugation in LDL lipids: an indicator of circulating oxidized LDL. Free Radic Biol Med 1999;27:1141-50.
3. Ait-Oufella H, Taleb S, Mallat Z, Tedgui A. Recent advances on the role of cytokines in atherosclerosis. Arterioscler Thromb Vasc Biol 2011;31:969-79.
4. Assmann G, Schulte H, von Eckardstein A. Hypertriglyceridemia and elevated lipoprotein (A) are risk factors for major coronary events in middle-aged men. Am J Cardiol 1996;77:1179-84.
5. ATSDR, Agency for Toxic Substances and Disease Registry. Draft toxicological profile for cadmium. Atlanta, GA: ATSDR, 2008.
6. Aviram M, Rosenblat M, Billecke S, Erogul J, Sorenson R, Bisgaier CL et al. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Radic Biol Med 1999;26:892-904.
7. Beadling CB, Smith KA. DNA array analysis of interleukin-2-regulated immediate/early genes. Med Immunol 2002;1(1):2.
8. Brown G, Albers JJ, Fisher LD, Schaefer SM, Lin JT, Kaplan C et al. Regression of the coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 1990;323:1289-98.
9. Bruunsgaard H, Andersen-Ranberg K, Jeune B, Pedersen AN, Skinhoj P, Pedersen BK. A high plasma concentration of TNFalpha is associated with dementia in centenarians. J Gerontol A Biol Sci Med Sci 1999;54:357-64.
10. Cerne D, Lukac-Bajalo J. Oxidative stress assays for disease risk stratification. Acta Pharm 2006;56:1-17.
11. Dan G, Lall SB, Rao DN. Humoral and cell mediated immune response to cadmium in mice. Drug Chem Toxicol 2000;23:349-60.
12. Deakin S, Moren X, James RW. HDL oxidation compromises its influence on paraoxonase-1 secretion and its capacity to modulate enzyme activity. Arterioscler Thromb Vasc Biol 2007;27:1146-52.
13. Dubinski A, Zdrojewicz Z. The role of interleukin-6 in development and progression of atherosclerosis. Pol Merkur Lekarski 2007;22:291-4.
14. EFSA. Cadmium in food. EFSA Journal 2009;980:1-139.
15. Febbraio MA, Pedersen BK. Contractioninduced myokine production and release: is skeletal muscle an endocrine organ? Exerc Sport Sci Rev 2005;33:114-49.
16. Furlong CE, Richter RJ, Seidel, Motulsky AG. Spectrophotometric assays for the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase/arylesterase. Anal Biochem 1989;180:242-7.
17. Gidez LT, Miller GH, Burnstein M, Slagle S, Eder HA. Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. J Lipid Res 1982;23:1206-23.
18. Ginsberg HN. Lipoprorein metabolism and its relationship to atherosclerosis. Med Clin North Am 1994;78:1-20.
19. Glass CK, Witztum JL. Atherosclerosis the road ahead. Cell 2001;104:503-16.
20. Glew RH, Kassam HA, Bhanji RA, Okorodudu A, VanderJagt DJ. Serum lipid profiles and risk of cardiovascular disease in three different male populations in northern Nigeria. J Health Popul Nutr 2002;20:166-74.
21. Haddy N, Sass C, Droesch S, Zaiou M, Siest G, Ponthieux A et al. IL-6, TNF-alpha and atherosclerosis risk indicators in a healthy family population: the STANISLAS cohort. Atherosclerosis 2003;170: 277-83.
22. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-95.
23. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta analysis of population-based prospective studies. J Cardiovasc Risk 1996; 3:213-9.
24. Järup L. Hazards of heavy metal contamination. Br Med Bull 2003;68:167-82.
25. Janabi M, Yamashita S, Hirano K, Sakai N, Hiraoka H, Matsumoto K et al. Oxidized LDL-induced NF-kappa B activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients. Arterioscler Thromb Vasc Biol 2000;20: 1953-60.
26. Kataranovski M, Kataranovski D, Savic D, Jovcic G, Bogdanovic Z, Jovanovic T. Granulocyte and plasma cytokine activity in acute cadmium intoxication in rats. Physiol Res 1998;47:453-61.
27. Kumon Y, Nakauchi Y, Suehiro T, Suehiro T, Shiinoki T, Tanimoto N et al. Proinflammatory cytokines but not acute phase serum amyloid A or reactive protein, downregulates paraoxonase 1 (PON1) expression by HepG2. Amyloid 2002;9:160-4.
28. Lafuente A, Cano P, Esquifino A. Are cadmium effects on plasma gonadotropins, prolactin, ACTH, GH and TSH levels, dose dependent? Biometals 2003;16:243-50.
29. Lafuente A, González-Carracedol A, Esquifino AI. Differential effects of cadmium on blood lymphocyte subsets. Biometals 2004;17:451-6.
30. Larregle EV, Varas SM, Oliveros LB, Martinez LD, Antón R, Marchevsky E et al. Lipid in liver of rat exposed to cadmium. Food Chem Toxicol 2008;46:1786-92.
31. Mackness MI, Mackness B, Durrington PN, Fogelman AM, Berliner J, Lusis AJ et al. Paraoxonase and coronary heart disease. Curr Opin Lipidol 1998;9:319-24.
32. Mackness B, Durrington P, McElduff P, Yarnell J, Azam N, Watt M et al. Low paraoxonase activity coronary events in the Caerphilly Prospect Study. Circulation 2003;107:2775-9.
33. Marth E, Barth S, Jelovcan S. Influence of cadmium on the immune system. Description of stimulating reactions. Centr Eur J Public Health 2000;8:40-4.
34. Monaco C, Andreakos E, Kiriakidis S, Mauri C, Bicknell C, Foxwell B et al. Canonical pathway of nuclear factor kappa B activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis. Proc Natl Acad Sci USA 2004;101:5634-9.
35. Nakagawa H, Nishijo M, Morikawa Y, Miura K, Tawara K, Kuriwaki J et al. Urinary cadmium and mortality among inhabitants of a cadmium-polluted area in Japan. Environ Res 2006;100:323-9.
36. Nawrot TS, Van Hecke E, Thijs L, Richart T, Kuznetsova T, Jin Y et al. Cadmiumrelated mortality and long-term secular trends in the cadmium body burden of an environmentally exposed population. Environ Health Perspect 2008;116:1620-8.
37. Nourooz-Zadeh J, Tajaddini-Sarmadi J, Wolff SP. Measurement of plasma hydroperoxide concentrations by the ferrous oxidation-xylenol orange assay in conjunction with triphenylphosphine. Anal Biochem 1994;220:403-9.
38. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Ann Biochem 1979;95:351-8.
39. Quinn MT, Parthasarathy S, Fong LG, Steinberg D. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci USA 1987 84:2995-8.
40. Ramirez DC, Giménez MS. Lipid modification in mouse peritoneal macrophages alter chronic cadmium exposure. Toxicology 2002;172:1-12.
41. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000 101:1767-72.
42. Sacan O, Yanardag R, Bolkent S, Bilgin-Sokmen B, Tunali S. Protective effects of selenium, vitamin C and E combination on cadmium-induced toxicity in various tissues of rats. Fresenius Environ Bull 2007;16: 839-45.
43. Shook LB, Laskin DL. Xenobiotics and inflammation. New York: Academic Press, 1994.
44. Twisk J, Gillian-Daniel DL, Tebon A, Wang L, Barrett PHR, Attie AD. The role of the LDL receptor in apolipoprotein B secretion. J Clin Invest 2000;105:521-32.
45. Upadhya S, Mooteri S, Peckham N, Pai RG. Atherogenic effect of interleukin-2 and antiatherogenic effect of interleukin-2 antibody in apo-E-deficient mice. Angiology 2004;55:289-94.
46. Villanueva MBG, Koizumi S, Jonai H. Cytokine production by human peripheral blood mononuclear cells after exposure to heavy metals. J Health Sci 2000;46:358-62.
47. von der Thusen JH, Kuiper J, van Berkel TJ, Biessen EA. Interleukins in atherosclerosis: molecular pathways and therapeutic potential. Pharmacol Rev 2003;55:133-66.
48. Waalkes MP, Rehm S. Carcinogenicity of oral cadmium in the male Wistar (WF/NCr) rat: Effect of chronic dietary zinc deficiency. Fund Appl Toxicol 1992;19:512-20.
49. Weber C, Zernecke A, Libby P. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat Rev Immunol 2008;8:802-15.
50. Weglarz L, Parfiniewicz B, Mertas A, Kondera-Anasz Z, Jaworska-Kik M, Dzierzewicz Z et al. Effect of endotoxins isolated from desulfovibrio desulfuricans soil and intestinal strain on the secretion of TNF-α by human mononuclear cells. Pol J Environ Stud 2006;15:615-22.
51. WHO, World Health Organization. Cadmium in drinking-water, background document for development of WHO Guidelines for Drinking-water Quality 2011;1-16.
52. Witztum JL, Steinberg D. Role of oxidised LDL in atherogenesis. J Clin Invest 1991; 88:1785-92.
53. Wojciak-Stothard B, Entwistle A, Garg R, Ridley AJ. Regulation of TNF-alphainduced reorganization of the actin cytoskeleton and cell-cell junctions by Rho, Rac, and Cdc42 in human endothelial cells. J Cell Physiol 1998;176:150-65.
54. Zahid IR, Song-hua HU, Chen-wen X, Abdullah GA. Adjuvant effects of saponins on animals immune responses. J Zhejiang Univ Sci B 2007;8:153-61.
55. Zhang W, Pang F, Huang Y, Ping Y, Lin W. Cadmium exerts toxic effects on ovarian steroid hormone release in rats. Toxicol Lett 2008;182:18-23.
56. Zilversmit, DB. Atherogenesis: a postprandial phenomenon. Circulation 1979;60:473-85.